CINCINNATI--(BUSINESS WIRE)--Feb. 24, 2005--Chemed Corporation
("Chemed") (NYSE:CHE) today finalized its amended and restated bank
credit facility. JPMorgan Chase Bank acted as both the agent and
arranger for this transaction.
The amended facility provides for (i) an increase in the aggregate
amount of the term loan (TL) from $35 million to $85 million at a
current rate of LIBOR plus 2.0% and (ii) an increase of its revolving
credit facility (RCF) from $100 million to $175 million at a current
rate of LIBOR plus 2.5%. The TL has 21 aggregate quarterly principal
payments of $212,500 with the balance due on August 24, 2010. The RCF
has a termination date of February 24, 2010.
Listed on the New York Stock Exchange and headquartered in
Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two
wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is
the nation's largest provider of end-of-life hospice care and
Roto-Rooter is the nation's leading provider of plumbing and drain
Statements in this press release or in other Chemed communications
may relate to future events or Chemed's future performance. Such
statements are forward-looking statements and are based on present
information Chemed has related to its existing business circumstances.
Investors are cautioned that such forward-looking statements are
subject to inherent risk that actual results may differ materially
from such forward-looking statements. Further, investors are cautioned
that Chemed does not assume any obligation to updated forward-looking
statements based on unanticipated events or changed expectations.
CONTACT: Chemed Corporation
David P. Williams, 513-762-6901
SOURCE: Chemed Corporation